What life sciences communicators need to do differently in 2027

When I first started working with life science organizations more than 25 years ago, I was drawn to the strong sense of purpose that connects employees to patients, scientific discovery and improving quality of life. I still am. But after working with dozens of clients, teams, and challenges, one of the things I love most about this industry is its complexity.  

Within a single organization, scientists, regulatory experts, manufacturing employees and commercial teams may all work toward the same mission, while experiencing the business very differently. 

In 2026, that complexity has never been clearer. AI adoption, competition for specialized talent and major business transitions—including renewed biotech IPO and M&A activity—set the stage for rapid change and brand-new expectations. 

Life sciences leaders are navigating interconnected decisions about where to invest, how to evolve their organizations, what capabilities they’ll need and how to balance speed with risk. For internal communicators, the challenge isn’t just explaining these decisions to employees. It’s understanding the business pressures behind them well enough to help leaders anticipate how those decisions will play out across the organization. 

That’s a challenge and an opportunity. In 2027, the most effective communicators will focus on becoming trusted advisors: the person who understands the business, brings employee perspectives into strategic decisions and recognizes where communications can meaningfully influence an outcome, and when it can’t. 

This piece explores how the life sciences industry has evolved in 2026, what those changes reveal about the role of internal communications and how IC leaders can position themselves to contribute more strategically in 2027. 

AI adoption is accelerating. IC needs to help organizations navigate the uncertainty.  

What happened in 2026

Many organizations are still figuring out how to translate AI investments into meaningful changes in how work gets done.  

According to Deloitte’s 2026 Life Sciences Outlook, 78% of surveyed biopharma and medtech executives expected AI to play a central role in driving major change, but only 14% reported fully integrating AI into daily workflows.  

As organizations move from experimentation toward implementation, employees are being asked to navigate a future in which their responsibilities, workflows and expectations aren’t yet fully defined.

The challenge for internal communicators

Leaders may have a clear vision for what AI can accomplish, but far less clarity about what it will mean for the people doing the work. 

And employees may experience that uncertainty differently depending on their functions:  

• Scientists may have questions about how AI-generated insights fit into research and decision-making.  
• Regulatory and quality teams may be concerned about security, reliability, validation and accountability.  
• Commercial teams may be navigating new tools and expectations around efficiency and productivity.  

Often, internal communicators are expected to address these concerns even when leadership doesn’t have definitive answers about what comes next.  

Traditional change communications often assumes that leadership can articulate a future state, and communicators can help employees understand how to get there. AI transformation requires a different approach. 

The opportunity

Rather than waiting for all the answers, internal communicators can help organizations communicate effectively through uncertainty.  

The first step is to help leadership distinguish between communications challenges and workplace barriers. Adoption issues don’t always stem from a lack of awareness or understanding. It’s possible that the technology doesn’t fit naturally into existing workflows, employees lack the necessary training, or expectations for how and when to use it are unclear.  

Employee insights can identify these barriers. Lean into ongoing employee listening, and bring results to the appropriate partners across HR, IT and business leadership. Employee listening can also help leaders understand how different functions are experiencing AI adoption and where concerns or questions are emerging.  

Finally, help leadership establish a consistent narrative around the purpose of AI adoption. Advise them on how to be transparent about what they do know, what’s still being determined and how decisions will be made. And equip managers to have meaningful conversations with employees about evolving expectations, even when they can’t provide certainty about every aspect of the change.  

And as AI changes how communications work gets done, it’s an opportunity for IC leaders to rethink where they spend their time and how they add value. Producing content more efficiently is useful. Bringing stronger business judgment and strategic counsel to the table is where the real opportunity lies. 

A competitive talent pool requires true cultural differentiation.

What happened in 2026 

BioSpace’s 2026 U.S. Life Sciences Employment Outlook found that 64% of surveyed biopharma employers were actively recruiting at the end of 2025, compared with 59% in the previous survey. Research and development and clinical roles were among the areas with particularly strong hiring demand. At the same time, BioSpace found that 64% of employed or contract biopharma professionals surveyed planned to actively look for work in 2026.  

These findings suggest that even amid layoffs and uneven hiring, life sciences employers can’t assume their talent will stay. Organizations need to give current and prospective employees compelling reasons to choose them.  

The challenge for internal communicators

Life sciences organizations are competing for highly specialized talent, often with similar missions and promises to employees. Purpose attracts talent, but it’s not always enough to retain them.  

As AI changes the skills organizations need and the way employees work, the employee value proposition also needs to account for how people will grow and adapt. 

Employees aren’t just asking if they should join or stay with an organization. They want to know if they’ll have opportunities to develop new capabilities, how they’ll navigate changing expectations, and if they can build a meaningful future at your organization.  

What truly differentiates organizations is how they operate, how leaders behave and what it actually feels like to work there. This makes the connection between an organization’s cultural promises and its actual approach to learning, development and career growth increasingly important. 

But IC may be responsible for communicating the organization’s cultural differentiators without having a clear, evidence-based understanding of what employees genuinely value, or whether the organization’s promises match their experiences.  

The evolving opportunity

Internal communicators can help their organizations articulate an authentic value proposition that current employees recognize and prospective employees can trust.  

A strong EVP starts with using employee listening, organizational research and cross-functional relationships to identify the behaviors, experiences and organizational strengths employees value most. Additionally, identify where cultural promises are credible, where they may be overstated and where the organization has meaningful strengths that aren’t being communicated effectively.  

Then, partner with HR to ensure those insights inform the EVP, employer brand and retention strategies. This is also an opportunity to share insights with leadership. Help them understand what needs to happen within the organization to reinforce its differentiators, including where leadership behaviors or everyday practices could be undermining the experience it promises.  

→ Read more: What you need to know about EVPs 

A new wave of IPOs and organizational changes are raising the stakes for IC.

What happened in 2026

In 2026, renewed biotech IPO activity provided a particularly visible example of how quickly an organization’s circumstances can change. After just 15 U.S. biopharma IPOs in 2025, the market saw renewed momentum in 2026, including record-setting offerings. Mergers and acquisitions have also seen increased activity. In the first half of 2026 alone, 86 M&A transactions closed, representing a total deal value of $196 billion. That’s a 141% increase from the same period in 2025, and the highest start to the year since 2019.  

Not every organization is going public or acquiring new businesses, but life sciences organizations regularly experience significant transitions—from clinical milestones and commercialization to mergers, restructuring and expansion. Whatever 2027 brings, these transitions will continue to test organizations’ ability to align their people, priorities and ways of working. These moments can reveal gaps between an organization’s stated culture and the behaviors its systems and leaders actually reinforce.

The challenge for internal communicators

Internal communicators are often brought into major organizational transitions to help explain what’s changing, maintain employee confidence and build alignment around a new direction. But the success of these transitions depends on more than employees understanding the strategy.  

Employees might need to collaborate differently, navigate new decision-making structures or adjust to expectations that weren’t part of the organization’s previous culture.  

For example:  

• M&A requires employees from different organizations to navigate new leadership structures, expectations and ways of working.  
• IPOs introduce new demands around accountability, governance and business performance that can influence decision-making and organizational culture. 
• Commercialization introduces new employee groups, priorities and operating rhythms as an organization evolves beyond its R&D focus.  

Although communicators can often recognize where these changes will create confusion, resistance or cultural misalignment, they aren’t always involved early enough to influence how the transition is planned.  

The evolving opportunity

This is a time for communicators to move beyond developing a communications strategy for organizational change. Instead, internal communicators should evolve their roles to help leadership anticipate the employee and cultural implications of business decisions.  

Start with employee insights. Bring data into leadership conversations before decisions are finalized, particularly when new expectations could conflict with established ways of working. If you can understand what will need to change operationally for a strategy to succeed, you can also identify the behaviors and aspects of the culture that either need to be preserved or evolve to support it.  

Successful change often requires adjustments to systems, incentives or leadership behaviors rather than additional communication. Speak up when another message isn’t the solution. 

What life sciences communicators should prioritize in 2027

1. Connect employee insights to business priorities. 

To become more effective strategic advisors, life sciences communicators need a deep understanding of the business, including its scientific, regulatory and commercial priorities, and the milestones that create pressure across different functions.  

Go beyond understanding what leadership is prioritizing to understanding why.  

• What competing demands are leaders balancing?  
• Where are they making difficult trade-offs between speed, cost, risk and long-term growth?  
• What assumptions are shaping their decisions? 
• What employee or organizational perspectives might help them make better-informed choices?  

Communicators also have a unique vantage point across the organization, with visibility into how scientists, regulatory experts, manufacturing employees, commercial teams and corporate functions experience those priorities differently.  

The opportunity is to connect those two perspectives. Use knowledge of business objectives alongside employee listening and organizational research to identify potential barriers, opportunities and unintended consequences that leadership may not recognize. Then translate those observations into insights that are relevant to business decisions, rather than simply reporting employee sentiment or communications performance.  

2. Be intentional about where and how you influence decisions. 

The challenges facing life sciences organizations increasingly require solutions that cross functional boundaries.  

AI adoption, talent retention and organizational transformations all depend on decisions made across HR, IT, operations, commercial functions and leadership.  

As IC becomes more involved in these issues, communicators need to understand where they can meaningfully influence outcomes and where accountability belongs elsewhere.  

When recommending a course of action, consider what needs to happen beyond communications:  

• If employees are hesitant to adopt AI, is the barrier a lack of understanding, or insufficient training and clear guidelines?  
• If your EVP isn’t resonating, is the issue how it’s being communicated, or a disconnect between the promise and the actual experience?  
• If employees are struggling through a merger, do they need clearer messaging, or are conflicting processes and leadership expectations creating confusion?  

Use evidence and cross-functional relationships to bring those issues into leadership conversations, even when doing so requires challenging the original request.

3. Find the right strategic support

As expectations for IC grow, communicators are being asked to contribute more strategically all while continuing to manage day-to-day responsibilities. In life sciences, this pressure can be particularly significant during commercialization, M&A, restructuring and other major transitions, when communication needs expand quickly without corresponding increases in headcount.  

External partners can help address these challenges, but the value they provide should extend beyond additional production capacity.  

Look for partners who offer three capabilities: 

1. Deep industry expertise

A partner who understands life sciences business rhythms, specialized employee audiences and major organizational milestones can contribute without a lengthy onboarding process.  

2. Senior-level strategic counsel

The right partner can help IC leaders navigate difficult leadership conversations, connect employee insights to business priorities and determine when communication alone won’t achieve the desired outcome.  

3. Flexible support

A partner should be able to move between strategic conversations and practical execution as the organization’s needs evolve.  

For bink, being an extension of the internal team means bringing industry knowledge and an outside perspective while helping communicators build their own strategic capabilities.